Direct oral anticoagulants in patients with venous thromboembolism: current challenges in everyday practice
{{output}}
Direct oral anticoagulants (DOACs) have transformed venous thromboembolism (VTE) treatment by offering predictable pharmacokinetics and eliminating routine monitoring requirements. Despite robust clinical trial evidence supporting their efficacy, real‑world i... ...
